Altruist Biologics secures NMPA license, expanding its Hangzhou facility to solidify its role in China's rapidly growing ...

Neuland Laboratories appoints Saharsh Davuluri as CEO to lead its $30m peptide facility expansion, targeting growth in ...

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

Despite persistent cost concerns, continued innovation is reinforcing the chromatography resin market’s long-term growth.

Explore the latest news and expert commentary by Steven Gravallese, brought to you by the Contributor of BioProcess ...

Drug developers weigh building internal radiopharmaceutical capabilities versus outsourcing amid timeline and funding ...

Leaders from around the industry discuss areas that stakeholders can explore to lower costs and improve accessibility.

Amid growing financial concerns and US vaccine hesitancy, the German company will close its mRNA site in Southeast Asia.

ABK Biomedical is building a Missouri facility to produce Eye90 microspheres, advancing radiopharmaceuticals for liver cancer ...

President Trump enacts tariffs on imported drugs to strengthen US manufacturing, sparking industry concerns over costs, ...

Explore the latest news and expert commentary by Stephen Cheng, brought to you by the Contributor of BioProcess International ...

Learn how relative quantification provides coverage of the total host cell protein population, enabling assessment of process ...